Funder: The Medtronic Foundation
Reach first began in April 2015 as a 5-year initiative with a mission to promote the health of vulnerable populations through technical support to local, regional and global efforts to prevent and control Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD).
Reach provides technical support and policy translation to amplify rheumatic heart disease control efforts locally, regionally and globally. As an organisation they aim to identify, describe and disseminate solutions for this neglected disease and to reduce the burden on vulnerable populations around the world. As a collaborative organisation, they partner with a broad range of stakeholders – including clinicians, other disease communities, academics, donors, governments, industry and people living with RHD – to achieve their common goals.
